title: Prolonged B-cell depletion following rituximab therapy in systemic lupus erythematosus: a report of two cases.
authors.affiliation: Department of Rheumatology, The Karolinska University Hospital,The Karolinska Institutet, Stockholm, Sweden.
authors.forename: T Y-T
authors.initials: TY
authors.lastname: Lu
authors.forename: T
authors.initials: T
authors.lastname: Jónsdóttir
authors.forename: T
authors.initials: T
authors.lastname: Jonsdottir
authors.forename: R F
authors.initials: RF
authors.lastname: van Vollenhoven
authors.forename: D A
authors.initials: DA
authors.lastname: Isenberg
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D001402:B-Lymphocytes / Q000187:drug effects*; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy*; D018655:Lymphocyte Count; D008212:Lymphocyte Depletion; D000069283:Rituximab; D013997:Time Factors
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D007166:Immunosuppressive Agents; D000069283:Rituximab